Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

January 30, 2025

Conditions
Insulin Sensitivity/Resistance
Interventions
DRUG

Metformin

Metformin is a drug used to manage blood glucose levels. It improves insulin sensitivity and reduces glucose production in the liver. This regimen will be provided to all study groups (A, B, and C) in combination with the respective interventions described for each group. Participants are instructed not to change their physical activity during the study.

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
collaborator

National Police Hospital

OTHER_GOV

lead

Cairo University

OTHER